332 related articles for article (PubMed ID: 35515016)
21. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of periostin in lung cancer-related malignant pleural effusion.
Zhang J; Zha T; Zhang N; Sun G
J Clin Lab Anal; 2022 Feb; 36(2):e24179. PubMed ID: 35152510
[TBL] [Abstract][Full Text] [Related]
23. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
Li CS; Cheng BC; Ge W; Gao JF
Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
[TBL] [Abstract][Full Text] [Related]
24. A simple and efficient clinical prediction scoring system to identify malignant pleural effusion.
Wang S; An J; Hu X; Zeng T; Li P; Qin J; Shen Y; Wang T; Wen F
Ther Adv Respir Dis; 2024; 18():17534666231223002. PubMed ID: 38189181
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of cytokeratin 19 fragment (CYFRA 21-1) as a tumor marker in malignant pleural effusion.
Lai RS; Chen CC; Lee PC; Lu JY
Jpn J Clin Oncol; 1999 Sep; 29(9):421-4. PubMed ID: 10563194
[TBL] [Abstract][Full Text] [Related]
26. The diagnostic value of pleural fluid homocysteine in malignant pleural effusion.
Santotoribio JD; Del Valle-Vazquez L; García-de la Torre A; Del Castillo-Otero D; Lopez-Saez JB; Sanchez Del Pino MJ
PLoS One; 2019; 14(9):e0222616. PubMed ID: 31550262
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions.
Korczynski P; Krenke R; Safianowska A; Gorska K; Abou Chaz MB; Maskey-Warzechowska M; Kondracka A; Nasilowski J; Chazan R
Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):128-33. PubMed ID: 20156743
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of serum and pleural levels tumor M2-pyruvate kinase in lung cancer patients with pleural effusion.
Zhang T; Liu W; Li L; Jue Z; Xu C
BMC Pulm Med; 2022 Aug; 22(1):307. PubMed ID: 35948914
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of tumour markers in pleural effusions.
Volarić D; Flego V; Žauhar G; Bulat-Kardum L
Biochem Med (Zagreb); 2018 Feb; 28(1):010706. PubMed ID: 29472801
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic Accuracy of Combinations of Tumor Markers for Malignant Pleural Effusion: An Updated Meta-Analysis.
Yang Y; Liu YL; Shi HZ
Respiration; 2017; 94(1):62-69. PubMed ID: 28427079
[TBL] [Abstract][Full Text] [Related]
31. Pleural carbohydrate antigen 50 and malignant pleural effusion: a prospective, double-blind diagnostic accuracy test.
Cha SN; Niu Y; Wen JX; Yan C; Yang Q; Zhu HZ; Lin X; Cao XS; Gao WH; Wang YF; Zhou F; Yan L; Zheng WQ; Hu ZD
Transl Lung Cancer Res; 2024 May; 13(5):1061-1068. PubMed ID: 38854948
[TBL] [Abstract][Full Text] [Related]
32. Use of tumor markers in distinguishing lung adenocarcinoma-associated malignant pleural effusion from tuberculous pleural effusion.
Ai L; Wang W; Li J; Ye T; Li Y
Am J Med Sci; 2024 Apr; ():. PubMed ID: 38583522
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of malignant pleural effusion with combinations of multiple tumor markers: A comparison study of five machine learning models.
Zhang Y; Wang J; Liang B; Wu H; Chen Y
Int J Biol Markers; 2023 Jun; 38(2):139-146. PubMed ID: 36847282
[TBL] [Abstract][Full Text] [Related]
34. The Diagnosis of Malignant Pleural Effusion Using Tumor-Marker Combinations: A Cost-Effectiveness Analysis Based on a Stacking Model.
Wang J; Zhou J; Wu H; Chen Y; Liang B
Diagnostics (Basel); 2023 Oct; 13(19):. PubMed ID: 37835879
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of the diagnosis value of carcinoembryonic antigen in malignant pleural effusion].
Yu YX; Tong ZH; Zhou XX; Liang LR; Wang Z; Xu LL; Wang XJ; Wu YB; Li HJ; Lu Z
Zhonghua Yi Xue Za Zhi; 2018 Feb; 98(6):432-435. PubMed ID: 29429254
[No Abstract] [Full Text] [Related]
36. Diagnostic utility of LDH, CA125 and CYFRA21-1 in tuberculosis pleural effusion.
Lin H; Ni L
Med Clin (Barc); 2022 Jan; 158(2):70-72. PubMed ID: 33495032
[TBL] [Abstract][Full Text] [Related]
37. The value of apolipoprotein E in distinguishing benign and malignant unilateral pleural effusions.
Xue Q; Fang G; Deng X; Zhang C; Liu Z; Peng Z; Lai Z; Peng Y; Wu J
Medicine (Baltimore); 2020 Mar; 99(10):e19320. PubMed ID: 32150067
[TBL] [Abstract][Full Text] [Related]
38. Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid.
Bixby B; Vrba L; Lenka J; Oshiro MM; Watts GS; Hughes T; Erickson H; Chopra M; Knepler JL; Knox KS; Jarnagin L; Alalawi R; Kala M; Bernert R; Routh J; Roe DJ; Garland LL; Futscher BW; Nelson MA
Sci Rep; 2024 Feb; 14(1):2939. PubMed ID: 38316884
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in malignant pleural effusion in patients with lung cancer.
Xu CH; Hao KK; Yu LK; Zhang XW
Asia Pac J Clin Oncol; 2015 Mar; 11(1):28-33. PubMed ID: 24720371
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of serum and pleural levels of the tumor markers CEA, CYFRA21-1 and CA 15-3 in patients with pleural effusion.
Wagner IC; Guimarães MJ; da Silva LK; de Melo FM; Muniz MT
J Bras Pneumol; 2007; 33(2):185-91. PubMed ID: 17724538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]